Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Payables (2020 - 2026)

Sotera Health has reported Payables over the past 6 years, most recently at $78.0 million for Q4 2025.

  • For Q4 2025, Payables rose 41.5% year-over-year to $78.0 million; the TTM value through Dec 2025 reached $78.0 million, up 41.5%, while the annual FY2025 figure was $78.0 million, 41.5% up from the prior year.
  • Payables for Q4 2025 was $78.0 million at Sotera Health, up from $61.4 million in the prior quarter.
  • Over five years, Payables peaked at $78.0 million in Q4 2025 and troughed at $51.8 million in Q3 2021.
  • A 5-year average of $63.6 million and a median of $62.5 million in 2021 define the central range for Payables.
  • Biggest five-year swings in Payables: decreased 22.44% in 2024 and later skyrocketed 41.5% in 2025.
  • Year by year, Payables stood at $72.9 million in 2021, then rose by 1.74% to $74.1 million in 2022, then decreased by 4.18% to $71.0 million in 2023, then decreased by 22.44% to $55.1 million in 2024, then skyrocketed by 41.5% to $78.0 million in 2025.
  • Business Quant data shows Payables for SHC at $78.0 million in Q4 2025, $61.4 million in Q3 2025, and $63.7 million in Q2 2025.